Side-by-side comparison of AI visibility scores, market position, and capabilities
Digital health platform with 50M+ patients engaged and 4,500+ hospital deployments; holds FDA 510k clearance for RPM; acquired Aluna (respiratory monitoring) in May 2025 and launched Pfizer hemophilia cloud platform in Jan 2025.
Huma (formerly Medopad) is a London-based digital health company that operates a cloud-based remote patient monitoring (RPM) and decentralized clinical trial platform used by hospitals, health systems, pharmaceutical companies, and medical device manufacturers. Founded in 2011, Huma has grown to serve more than 4,500 hospitals and clinics worldwide, engaging over 50 million patients through its digital health platform. The company's FDA Class II 510k-cleared RPM solution combines a patient-facing mobile app with a clinician portal that enables real-time monitoring of vital signs, symptoms, and treatment adherence, reducing unnecessary hospital admissions and enabling earlier clinical intervention.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.